Biocartis SA
205.6 FTEBiocartis reported revenue of €48.2m for the 2025 financial year (annual accounts filed with the NBB on 08 Jun 2026), with 205.6 full-time equivalents.
The score of Biocartis shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Revenue -4 % Equity -19 % Total assets -36 % Headcount (avg FTE) -34 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Biocartis's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | €48.2m | ||||
| Net result | −€22.9m | ||||
| Equity | €37.2m | ||||
| Cash | €6.05m | ||||
| EBITDA | −€17.5m | ||||
| Total assets | €61.8m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 08 Jun 2026
- Year ended 31 Dec 2024filed on 15 May 2025
- Year ended 31 Dec 2023filed on 09 Jul 2024
- Year ended 31 Dec 2022filed on 22 May 2023
- Year ended 31 Dec 2021filed on 17 May 2022
Biocartis's financial analysis
- Solvency60.2%sector median: 60.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Biocartis
Biocartis's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0827.475.227
- VAT number
- BE0827475227
- Peppol
- Registered · 0208:0827475227 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 02 Jul 2010
- Registered office
- 2800 Mechelen
- Size
- Medium · 205.6 FTE
- Latest accounts
- 2025 · filed on 08 Jun 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
Biocartis (SA) has been based in Mechelen since 2010, active in: research and experimental development on biotechnology. For 2025, it reports revenue of €48.2m, a net loss of €22.9m and equity of €37.2m. With 205.6 full-time equivalents, it is a medium-sized enterprise by headcount. Its solvency stands at 60.2%, below the median of its sector (60.4%).
Guide: Checking a Belgian supplier invoice: numbers and IBAN →
Companies similar to Biocartis
Companies in the same business, of comparable size and area, outside its group.
- CellCarta Research and experimental development on natural sciences and engineering Antwerp · balance sheet €60.5m
- invoX Belgium Manufacture of pharmaceutical preparations Diepenbeek · balance sheet €29.2m
- Fujirebio Europe Manufacture of other chemical products n.e.c. Ghent · balance sheet €81.8m
- Kaneka Eurogentec Manufacture of pharmaceutical preparations Seraing · balance sheet €115.4m
- Diagenode Research and experimental development on natural sciences and engineering Seraing · balance sheet €21.1m
- LaCAR MDx technologies Manufacture of other special-purpose machinery n.e.c. Liège · balance sheet €29.1m
- Agilent Technologies Belgium Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €51.1m
- Belgian Volition Research and experimental development on natural sciences and engineering Gembloux · balance sheet €42.6m
Frequently asked questions about Biocartis
What is the revenue of Biocartis?
According to the 2025 annual accounts filed with the NBB, the revenue of Biocartis amounts to 48,220,328 €.
What is the VAT number of Biocartis?
In Belgium, the VAT number is the company number prefixed with BE: BE0827475227 for Biocartis, if the company is VAT-registered. Its company number (CBE) is 0827.475.227.
Where is the registered office of Biocartis?
According to the CBE register, the registered office of Biocartis is in 2800 Mechelen.
What is the equity of Biocartis?
At the close of the 2025 financial year, the equity of Biocartis amounts to 37,189,659 €, a solvency of 60.2% of total assets.
How many people work at Biocartis?
205.6 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Biocartis?
The register lists 3 active mandates at Biocartis. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Biocartis
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →